CHEOY:OTCMKTS
Cochlear Ord ADR
44,72 USD
arrow_downward
−0,07%(−0,030) 1D
15. lis, 16:00:00 GMT -4 · USD
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za CHEOY...
Otvori
44,61 USD
Najviša
44,82 USD
Najniža
44,60 USD
Trž. kap.
8,58 mlr.
Prosj. kol.
18,50 tis.
Količina
26,66 tis.
52-tjed. najviša
98,49 USD
52-tjed. najniža
31,82 USD
Beta
0,68
Dionice u optjecaju
130,80 mil.
Broj djelatnika
5 tis.
Otvori
44,61 USD
Najviša
44,82 USD
Najniža
44,60 USD
Trž. kap.
8,58 mlr.
Prosj. kol.
18,50 tis.
Količina
26,66 tis.
52-tjed. najviša
98,49 USD
52-tjed. najniža
31,82 USD
Beta
0,68
Dionice u optjecaju
130,80 mil.
Broj djelatnika
5 tis.
Vijesti
Iz web-izvora i od partnera za vijesti
Simply Wall Street
·
prije 14 sati
Cochlear And 2 Australian Healthcare Stocks To Watch
PR Newswire
·
prije 1 dan
Cochlear Named #1 Most Trustworthy Healthcare Company In The World For 2026
Profil
Cochlear is a medical device company that designs, manufactures, and supplies the Nucleus cochlear implant, the Hybrid electro-acoustic implant and the Baha bone conduction implant.
Based in Sydney, Cochlear was formed in 1981 as a subsidiary of Nucleus with finance from the Australian government to commercialise the implants pioneered by Dr. Graeme Clark, although the company later became separate. As of 2022, the company holds 50% of the cochlear implant market, with more than 250,000 people receiving one of Cochlear's implants as of 2015.
Cochlear was named Australia's most innovative company by the Intellectual Property Research Institute of Australia in 2002 and 2003, and one of the world's most innovative companies by Forbes in 2011. Wikipedia
Cochlear Ord ADR – informacije
Glavni izvršni direktorDig Howitt
Zaposlenici5,4 tis.
Osnovano1981
SjedišteSydney, Novi Južni Wales, Australija
Sektor-
Web-lokacijacochlear.com